5-methoxyindol-3-carboxaldehyde amino(pentylamino)methylenehydrazone hydrogen maleate,
HTF 919,
SDZ HTF 919,
SDZ HTF-919,
tegaserod,
tegaserod maleate,
Zelmac,
Zelnorm,
Tegaserod maleate,
Zelnorm,
Tegaserod (maleate),
189188-57-6,
UNII-E5XNT3RF5A,
Tegaserod,
HTF-919,
SDZ-HTF 919,
E5XNT3RF5A,
Tegaserod maleate [USAN],
Tegaserod maleate (USAN),
HTF 919,
MLS001401406,
SDZ-HTF-919,
CHEBI:51044,
SMR000471618,
SR-05000001865,
tegaserod-maleate,
Tegibs 6,
Hydrazinecarboximidamide, 2-((5-methoxy-1H-indol-3-yl)methylene)-N-pentyl-, (2Z)-2-butenedioate (1:1),
Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-, (2Z)-2-butenedioate (1:1),
Zelnorm (TN),
AC1OCFCM,
2-[(5-Methoxy-1H-indol-3-yl)methylene]-N-pentyl-hydrazinecarboximidamide maleate,
3-(5-Methoxy-1H-indol-3-ylmethylene)-N-pentylcarbazimidamide hydrogen maleate,
2-[(5-Methoxy-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide (2Z)-2-Butenedioate,
Tegaserod Hydrogen Maleate,
SCHEMBL27215,
SPECTRUM1505215,
CHEMBL1516474,
REGID_for_CID_6918369,
HMS1922N11,
Pharmakon1600-01505215,
CCG-40062,
HY-14153A,
NSC760425,
Tegaserod maleate, >=98% (HPLC),
AKOS024458253,
CS-4234,
NC00269,
NSC-760425,
NCGC00095144-01,
NCGC00095144-02,
AN-15007,
BC208394,
SAM001246606,
AB2000472,
TL8001540,
B7690,
D02730,
SR-05000001865-1,
maleic acid; 1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentyl-guanidine,
(Z)-but-2-enedioic acid; 1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentylguanidine,
Zelmac,
Tegaserod maleate[USAN],
D01AUI,
Tegaserod [USAN:INN:BAN],
SDZ HTF 919,
C16H23N5O,
C16H23N5O.C4H4O4,
SF303,
UNII-458VC51857,
C16-H23-N5-O,
CID6918369,
CPD000471618,
C16-H23-N5-O.C4-H4-O4,
A11743,
145158-71-0,
2-[(5-methoxy-1h-indol-3-yl)methylene]-n-pentylhydrazinecarboximidamide,